Authors: Fideleff, HL Boquete, HR Sequera, A Suarez, M Sobrado, P Giaccio, A

Citation: Hl. Fideleff et al., Peripubertal prolactinomas: Clinical presentation and long-term outcome with different therapeutic approaches, J PED END M, 13(3), 2000, pp. 261-267

Authors: Colao, A Marzullo, P Spiezia, S Giaccio, A Ferone, D Cerbone, G Di Sarno, A Lombardi, G

Citation: A. Colao et al., Effect of two years of growth hormone and insulin-like growth factor-I suppression on prostate diseases in acromegalic patients, J CLIN END, 85(10), 2000, pp. 3754-3761

Authors: Colao, A Marzullo, P Ferone, D Marino, V Pivonello, R Di Somma, C Di Sarno, A Giaccio, A Lombardi, G

Citation: A. Colao et al., Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly, J ENDOC INV, 22(1), 1999, pp. 40-47

Authors: Colao, A Marzullo, P Vallone, G Giaccio, A Ferone, D Rossi, E Scarpa, R Smaltino, F Lombardi, G

Citation: A. Colao et al., Ultrasonographic evidence of joint thickening reversibility in acromegalicpatients treated with lanreotide for 12 months, CLIN ENDOCR, 51(5), 1999, pp. 611-618

Authors: Colao, A Marzullo, P Spiezia, S Ferone, D Giaccio, A Cerbone, G Pivonello, R Di Somma, C Lombardi, G

Citation: A. Colao et al., Effect of growth hormone (GH) and insulin-like growth factor I on prostatediseases: An ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects, J CLIN END, 84(6), 1999, pp. 1986-1991